Predictive Intelligence

AI-Powered

Real-time risk scoring • Stop-loss forecasting • Intervention recommendations

Stop-Loss Breach Risk

AI-calculated probability of policy breach

0%
Specific (Any)
Increasing
45 days to risk
0%
Aggregate
Stable
Projected Overrun
$234K

Based on current trajectory, 3 members are projected to exceed specific deductibles with a combined exposure of $234K above stop-loss thresholds.

Model Performance

0.0%
Prediction Accuracy
Target: 90%
0.0%
Alert Precision
Target: 85%
0.0%
ROI Validation
Target: 88%
0.0%
F1 Score
Target: 85%
All models operating within target parameters

Claims Cost Projection

Monthly trend with AI forecast and confidence bands

ActualPredicted95% CI

Predictive Alerts

1 critical

Imminent Stop-Loss Breach

2 hours ago
Member: M-4521

Member projected to breach $275K specific deductible within 45 days. Current trajectory: $312K YE projection.

94% confidence
+$45K

GLP-1 Spend Trajectory

6 hours ago

Medication costs projected to increase 89% YoY if current enrollment trends continue. 23 new starts identified.

91% confidence
+$156K

Emerging High-Cost Cohort

1 day ago

AI detected 12 members with rapid risk score acceleration. Early intervention could prevent $380K in projected claims.

88% confidence
+$380K

Favorable Trend Detected

2 days ago

Musculoskeletal claims down 8.4% following physical therapy benefit enhancement. Projected annual savings: $127K.

96% confidence
$-127K

Risk Distribution

Member population by risk score

Low Risk
4,521
35.2%
Moderate
3,287
25.6%
Elevated
2,456
19.1%
High
1,823
14.2%
Critical
760
5.9%
AI Insight

760 members (5.9%) are in critical risk tier. Early intervention for this cohort could prevent an estimated $1.2M in avoidable claims over the next 12 months.

High-Risk Member Interventions

AI-recommended actions with projected savings

MemberRisk ScoreTrendPrimary ConditionYTD ClaimsProjectedStop-LossInterventionPotential SavingsStatus
M-4521
94
12Hemophilia A$249K$312KHighCare Management$45Kpending
M-7832
87
8Cancer - Breast$189K$245KHighOncology Review$38Kin-progress
M-2156
82
3Multiple Sclerosis$157K$198KMediumSpecialty Pharmacy$28Kcompleted
M-9443
78
8ESRD$142K$175KMediumTransplant Eval$52KIn-progress
M-3287
75
5CHF$129K$158KMediumRemote Monitoring$24Kpending
Total at Risk: $1.09M
Potential Savings: $187K